Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies

被引：20
|
作者：
Wolf, Isis [1 ,2 ]
Gratzke, Christian [1 ,2 ]
Wolf, Philipp [1 ,2 ]
机构：
[1] Univ Freiburg, Med Ctr, Dept Urol, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Freiburg, Germany
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
prostate cancer; prostate cancer stem cells; prostate cancer stem cell hypothesis; prostate cancer stem cell antigens; prostate cancer stem cell therapy; RADICAL PROSTATECTOMY; ANDROGEN DEPRIVATION; LUMINAL CELLS; IN-VITRO; EXPRESSION; MARKER; METASTASIS; RECURRENCE; RESISTANCE; CARCINOMA;
D O I：
10.3389/fonc.2022.935715
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite decades of research and successful improvements in diagnosis and therapy, prostate cancer (PC) remains a major challenge. In recent years, it has become clear that PC stem cells (PCSCs) are the driving force in tumorigenesis, relapse, metastasis, and therapeutic resistance of PC. In this minireview, we discuss the impact of PCSCs in the clinical practice. Moreover, new therapeutic approaches to combat PCSCs are presented with the aim to achieve an improved outcome for patients with PC.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical Success
    Desai, Amar
    Yan, Yan
    Gerson, Stanton L.
    STEM CELLS TRANSLATIONAL MEDICINE, 2019, 8 (01) : 75 - 81
  • [22] Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
    Walcher, Lia
    Kistenmacher, Ann-Kathrin
    Suo, Huizhen
    Kitte, Reni
    Dluczek, Sarah
    Strauss, Alexander
    Blaudszun, Andre-Rene
    Yevsa, Tetyana
    Fricke, Stephan
    Kossatz-Boehlert, Uta
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [23] Cancer stem cell-like cells mediate adaptive resistance to targeted cancer therapies
    Jokinen, E.
    Laurila, N.
    Koivunen, P.
    Koivunen, J. P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S194 - S195
  • [24] Molecular subtypes and perspectives of targeted therapies in prostate cancer
    Tibor, Szarvas
    Anita, Csizmarik
    Miklos, Szucs
    Peter, Nyirady
    ORVOSI HETILAP, 2019, 160 (07) : 252 - 263
  • [25] From Therapy Resistance to Targeted Therapies in Prostate Cancer
    Moreira-Silva, Filipa
    Henrique, Rui
    Jeronimo, Carmen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Castration-Resistant Prostate Cancer: Targeted Therapies
    Leo, S.
    Accettura, C.
    Lorusso, V.
    CHEMOTHERAPY, 2011, 57 (02) : 115 - 127
  • [27] Changing the History of Prostate Cancer with New Targeted Therapies
    Hernando Polo, Susana
    Moreno Munoz, Diana
    Rosero Rodriguez, Adriana Carolina
    Silva Ruiz, Jorge
    Rosero Rodriguez, Diana Isabel
    Counago, Felipe
    BIOMEDICINES, 2021, 9 (04)
  • [28] Targeted therapies and companion biomarkers in metastatic prostate cancer
    Auclin, E.
    Vano, Y. -A.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2014, 38 (01): : 31 - 37
  • [29] Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
    Elsaesser-Beile, U.
    Buehler, P.
    Wolf, P.
    CURRENT DRUG TARGETS, 2009, 10 (02) : 118 - 125
  • [30] Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies
    Wang, Hao
    Cui, Guihua
    Yu, Bo
    Sun, Meiyan
    Yang, Hong
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (17) : 1979 - 1993
12345